Literature DB >> 11173659

Value of p53 protein in biological behavior of basal cell carcinoma and in normal epithelia adjacent to carcinomas.

N C Demirkan 1, N Colakoglu , E Düzcan .   

Abstract

Mutations in p53 gene are the most frequent gene alterations in human cancer. In this study, we have used the monoclonal antibody (DO7) to evaluate the role of the p53 gene mutation in the progression of basal cell carcinomas towards invasion. We tested the positivity for p53 protein in tumor cells in six cases of basosquamous cell carcinoma (BSCC), in twelve cases of infiltrative basal cell carcinoma (IBCC) and twenty-four cases of non-infiltrative basal cell carcinoma (NIBCC) in order to evaluate its potential prognostic significance. We also tested the expression of p53 protein in normal epithelia adjacent to carcinomas in order to determine its role in tumor progression. p53 protein staining with some peripheral accentuation was identified in 42,9% of all groups. No correlation was found between the immunreactivity of p53 protein and recurrence, pattern of tumor, diameter of the tumors and sex. However, there were statistically significant differences in positivity of p53 protein in normal epithelia adjacent to carcinomas and age of patients (t value: 2,21; p: 0,034). Results of the study suggest that the increasein p53 mutation frequency of morphologically normal epidermis was related to age and was independent of the degree of differentiation of BCC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11173659     DOI: 10.1007/bf03187330

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  14 in total

1.  Sun-exposure- and aging-dependent p53 protein accumulation results in growth advantage for tumour cells in carcinogenesis of nonmelanocytic skin cancer.

Authors:  S B Liang; Y Ohtsuki; M Furihata; T Takeuchi; J Iwata; B K Chen; H Sonobe
Journal:  Virchows Arch       Date:  1999-03       Impact factor: 4.064

2.  p53 mutations and chromosome instability in basal cell carcinomas developed at an early or late age.

Authors:  M D'Errico; A S Calcagnile; R Corona; M Fucci; G Annessi; G Baliva; M E Tosti; P Pasquini; E Dogliotti
Journal:  Cancer Res       Date:  1997-02-15       Impact factor: 12.701

3.  Characterization of p53 gene mutations in basal-cell carcinomas: comparison between sun-exposed and less-exposed skin areas.

Authors:  Y Matsumura; C Nishigori; T Yagi; S Imamura; H Takebe
Journal:  Int J Cancer       Date:  1996-03-15       Impact factor: 7.396

4.  Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.

Authors:  T L Barrett; K J Smith; J J Hodge; R Butler; F W Hall; H G Skelton
Journal:  J Am Acad Dermatol       Date:  1997-09       Impact factor: 11.527

5.  Overexpression of p53 protein in basal cell carcinomas of human skin.

Authors:  C R Shea; N S McNutt; M Volkenandt; J Lugo; P G Prioleau; A P Albino
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

6.  Expression of p53 in premalignant and malignant squamous epithelium.

Authors:  B A Gusterson; R Anbazhagan; W Warren; C Midgely; D P Lane; M O'Hare; A Stamps; R Carter; H Jayatilake
Journal:  Oncogene       Date:  1991-10       Impact factor: 9.867

7.  Cell proliferation and p53 protein expressions in cutaneous epithelial neoplasms.

Authors:  H Onodera; S Nakamura; T Sugai
Journal:  Am J Dermatopathol       Date:  1996-12       Impact factor: 1.533

8.  Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms.

Authors:  M Sexton; D B Jones; M E Maloney
Journal:  J Am Acad Dermatol       Date:  1990-12       Impact factor: 11.527

9.  Frequent p53 accumulation in the chronically sun-exposed epidermis and clonal expansion of p53 mutant cells in the epidermis adjacent to basal cell carcinoma.

Authors:  Y Urano; T Asano; K Yoshimoto; H Iwahana; Y Kubo; S Kato; S Sasaki; N Takeuchi; N Uchida; H Nakanishi
Journal:  J Invest Dermatol       Date:  1995-06       Impact factor: 8.551

10.  Histologic evolution of basal cell carcinoma recurrence.

Authors:  A Y Dixon; S H Lee; D H McGregor
Journal:  Am J Dermatopathol       Date:  1991-06       Impact factor: 1.533

View more
  5 in total

1.  B-Raf mutations, microsatellite instability and p53 protein expression in sporadic basal cell carcinomas.

Authors:  Angeliki Stamatelli; Angelica A Saetta; Thaleia Bei; Nicolaos Kavantzas; Nicolaos V Michalopoulos; Efstratios Patsouris; Kiriaki Aroni
Journal:  Pathol Oncol Res       Date:  2011-01-28       Impact factor: 3.201

2.  Diagnosis of basal cell carcinoma by infrared spectroscopy of whole blood samples applying soft independent modeling class analogy.

Authors:  Mohammadreza Khanmohammadi; Razieh Nasiri; Keyvan Ghasemi; Simin Samani; Amir Bagheri Garmarudi
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-02       Impact factor: 4.553

3.  Caspase-3, p53 and Bcl-2 expression in basal cell carcinoma of the eyelid.

Authors:  Efe Koyun; Remzi Karadag; Seyma Ozkanli; Serpil Oguztuzun; Arzu Kaya Kocdogan; Isilay Ozsoy
Journal:  Postepy Dermatol Alergol       Date:  2020-09-02       Impact factor: 1.837

4.  Relation between expression pattern of p53 and survivin in cutaneous basal cell carcinomas.

Authors:  Marian Adamkov; Erika Halasova; Julius Rajcani; Marian Bencat; Desanka Vybohova; Silvia Rybarova; Stefan Galbavy
Journal:  Med Sci Monit       Date:  2011-02-25

5.  Integrated analysis of multimodal single-cell data.

Authors:  Yuhan Hao; Stephanie Hao; Erica Andersen-Nissen; William M Mauck; Shiwei Zheng; Andrew Butler; Maddie J Lee; Aaron J Wilk; Charlotte Darby; Michael Zager; Paul Hoffman; Marlon Stoeckius; Efthymia Papalexi; Eleni P Mimitou; Jaison Jain; Avi Srivastava; Tim Stuart; Lamar M Fleming; Bertrand Yeung; Angela J Rogers; Juliana M McElrath; Catherine A Blish; Raphael Gottardo; Peter Smibert; Rahul Satija
Journal:  Cell       Date:  2021-05-31       Impact factor: 41.582

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.